Table 2.
TDP-43 Mutation |
Epigenomic Alterations | Cellular Context | Refs. | |
---|---|---|---|---|
G294V | DNA damage/DSB TC-DSB | Mislocalization; | SH-S5Y5 | [97] |
R-loop accumulation; R-loop-dependent increased DSBs | ||||
Accumulation of FANCD2 repair foci (replication blockage). | ||||
G298S | DNA methylation |
Hyper- and hypo-methylated regions related to controls with common and specific DMRs related to other ALS hIPSCs-derived MNs (C9orf72-, TARDBP-, SOD1-, and FUS-mutation carriers). | hIPSCs-derived MNs from G298S carrier | [74] |
A315T | Chromatin remodeling | Diminution of nBAF chromatin-remodeling complex components (Brg1, BAF53b, and CREST). | Cultured mouse MNs | [57] |
DNA methylation |
Altered 5mC and 5hmC underlying their increased vulnerability to degeneration. | TDP-43A315T mouse CSMNs | [171] | |
DNA damage/DSB | Enhanced vulnerability to DNA damages. | MN-like NSC-34 cells | [95] | |
M323K | Autoregulation | Increased RNA, but not significant for protein. | Mouse TDP-43M323K knock-in | [167] |
Q331K | Autoregulation | Increase in RNA and nuclear protein in frontal cortex and spinal cords of mutant mice, but not in motor neuron. | Mouse TDP-43Q331K knock-in but not transgene | [168,169] |
DNA damage/DSB | Increased cytosolic sequestration of the poly-ubiquitinated and aggregated form, nuclear loss of function DNA damage induction, and DSB repair defects (preventing the nuclear translocation of XRCC4); Contribution to oxidative genome damage accumulation via increased reactive oxygen species (ROS). |
Spinal cord of ALS Q331K carriers, SH-S5Y5 |
[93] | |
Enhanced vulnerability to DNA damages (increase yH2Ax post damaging agent exposure). |
MN-like NSC-34 cells | [95] | ||
M337V | DNA methylation |
No global alteration in 5mC | SH-S5Y5 | [58] |
Histone PTMs | Significant decrease in global H3S10Ph-K14Ac; No significant increase in H3K9me3. |
|||
DNA damage/DSB | Impairment in the NHEJ DSB repair factors recruitment. | Fibroblasts of human M337V carrier | [95] | |
G348C | Autoregulation | Upstream intron1 promoter region of TARDBP binding but less efficient than WT for its repression; No significant activation of the intron 1 promoter. |
HEK293T | [170] |
A382T | DNA Methylation |
No global alteration in 5mC. | SH-S5Y5 | [58] |
Histone PTMs | No significant decrease in global H3S10Ph-K14Ac; No significant increase in H3K9me3. |
|||
DNA damage/DSB TC-DSB | Increased yH2Ax; R-loop accumulation; R-loop-dependent increased DSBs accumulation of FANCD2 repair foci (replication blockage). |
SH-S5Y5 LCL from A382T carriers |
[97] | |
Isoforms/fragments | Increased TDP-35 form at chromatin at R-loop. | LCL from A382T carriers | [97] | |
Autoregulation | Upstream intron1 promoter region of TARDBP binding but less efficient than WT for its repression; Able to induce a significant activation of the intron 1 promoter. |
HEK293T | [170] | |
N390D | DNA methylation |
Hyper- and hypo-methylated regions related to controls with common and specific DMRs related to other ALS hIPSCs-derived MNs (C9orf72-, TARDBP-, SOD1-, and FUS-mutation carriers). | hIPSCs-derived MNs from N390D carrier | [74] |
G418C | Chromatin remodeling | Diminution in nBAF chromatin-remodeling complex components (Brg1, BAF53b and CREST). | Cultured mouse MNs | [57] |
C9orf72 with loss of nuclear TDP-43 | DNA methylation |
Altered DNA 5mC and 5hmC in the CSMN without nuclear TDP-43 compared to residual C9orf72 CMSN without TDP-43 nuclear loss. | Residual lower MNs from post-mortem CSMN tissues of C9orf72 carriers | [73] |
MNs: motor neurons; CSMNs: corticospinal MNs; LCL: lymphoblastoid cell line.